Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis 25 November 2022 Lancet
Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria 23 November 2022
'Erythritol', a safe natural sweetener exhibits multi-stage anti-malarial activity by permeating into Plasmodium falciparum through aquaglyceroporin channel. 1 November 2022
Britain at its Best: Delivering opportunity for women and girls through malaria eradication 11 October 2022
Safety, Tolerability, and Parasite Clearance Kinetics in Controlled Human Malaria Infection after Direct Venous Inoculation of Plasmodium falciparum Sporozoites: A Model for Evaluating New Blood-Stage Antimalarial Drugs 11 October 2022 Am J Trop Med Hyg
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362 10 October 2022
New in vitro interaction-parasite reduction ratio assay for early derisk in clinical development of antimalarial combinations 5 October 2022
Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei 4 October 2022 Molecules (Basel, Switzerland)
Achieving Health for All and Meeting Sustainable Development Goals Through Inclusive Research and Development and Equitable Access 29 September 2022
Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2 21 September 2022
Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 18 September 2022
Tumor distribution by quantitative mass spectrometry imaging of the inhibitor of apoptosis protein antagonist xevinapant in patients with resectable squamous cell carcinoma of the head and neck (EudraCT Number: 2014-004655-31) 13 September 2022 Analytical chemistry
Susceptibilities of Ugandan plasmodium falciparum isolates to proteasome inhibitors 12 September 2022
Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine 7 September 2022 Mol Ther Methods Clin Dev